 |
PDBsum entry 4p3c
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Immune system
|
PDB id
|
|
|
|
4p3c
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
218 a.a.
|
 |
|
|
|
|
|
|
|
218 a.a.
|
 |
|
|
|
|
|
|
|
13 a.a.
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Immune system
|
 |
|
Title:
|
 |
Mt1-mmp:fab complex (form i)
|
|
Structure:
|
 |
Heavy chain fab fragment of antibody lem-2/15. Chain: h. Fragment: mt1-mmp v-b loop. Engineered: yes. Light chain fab fragment of antibody lem-2/15. Chain: l. Engineered: yes. Matrix metalloproteinase-14. Chain: m.
|
|
Source:
|
 |
Mus musculus. Organism_taxid: 10090. Expressed in: escherichia coli. Expression_system_taxid: 562. Homo sapiens. Human. Organism_taxid: 9606. Gene: mmp14. Expression_system_taxid: 511693.
|
|
Resolution:
|
 |
|
1.94Å
|
R-factor:
|
0.156
|
R-free:
|
0.200
|
|
|
Authors:
|
 |
H.Rozenberg,Y.Udi,I.Sagi
|
|
Key ref:
|
 |
Y.Udi
et al.
(2015).
Inhibition mechanism of membrane metalloprotease by an exosite-swiveling conformational antibody.
Structure,
23,
104-115.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
06-Mar-14
|
Release date:
|
17-Dec-14
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
No UniProt id for this chain
|
|
|
|
|
|
|
|
|
 |
 |
|
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
Chain M:
E.C.3.4.24.80
- membrane-type matrix metalloproteinase-1.
|
|
 |
 |
 |
 |
 |
Cofactor:
|
 |
Zn(2+)
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
Structure
23:104-115
(2015)
|
|
PubMed id:
|
|
|
|
|
| |
|
Inhibition mechanism of membrane metalloprotease by an exosite-swiveling conformational antibody.
|
|
Y.Udi,
M.Grossman,
I.Solomonov,
O.Dym,
H.Rozenberg,
V.Moreno,
P.Cuniasse,
V.Dive,
A.G.Arroyo,
I.Sagi.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Membrane type 1 metalloprotease (MT1-MMP) is a membrane-anchored,
zinc-dependent protease. MT1-MMP is an important mediator of cell migration and
invasion, and overexpression of this enzyme has been correlated with the
malignancy of various tumor types. Therefore, modulators of MT1-MMP activity are
proposed to possess therapeutic potential in numerous invasive diseases. Here we
report the inhibition mode of MT1-MMP by LEM-2/15 antibody, which targets a
surface epitope of MT1-MMP. Specifically, the crystal structures of Fab LEM-2/15
in complex with the MT1-MMP surface antigen suggest that conformational
swiveling of the enzyme surface loop is required for effective binding and
consequent inhibition of MT1-MMP activity on the cell membrane. This inhibition
mechanism appears to be effective in controlling active MT1-MMP in endothelial
cells and at the leading edge of migratory cancer cells.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
');
}
}
 |
| |